About Medtronic Bladder Control Therapy

btn-start-here-edfIf you’ve tried other treatments but are still dealing with bladder control problems, you might be relieved to hear about another option: Medtronic Bladder Control Therapy. Select any topic below, or select "Start here" to be guided through this exploration of Medtronic Bladder Control Therapy (Sacral Neuromodulation), delivered by the InterStim® System.


Get an overview of Medtronic Bladder Control Therapy

Medtronic Bladder Control Therapy is clinically proven to significantly improve bladder control in people who have not had success with or could not tolerate the side effects of other treatments.


Learn how Medtronic Bladder Control Therapy works

Medtronic Bladder Control Therapy helps to correct the communication problem between the bladder and the brain that could be causing symptoms like leaks, retention, and urgency-frequency.


Find out about step 1 – the evaluation

With the two-step process, you can test it out to see if Medtronic Bladder Control Therapy will work for you before making a long-term commitment. Step 1 is called an "evaluation."


Find out about step 2 – long-term Medtronic Bladder Control Therapy

If you experience a significant reduction in your bladder control symptoms during the evaluation, you and your doctor can discuss long-term Medtronic Bladder Control Therapy.


Get answers to common questions about Medtronic Bladder Control Therapy, the evaluation, and long-term therapy

How effective is this therapy? How will I know if the evaluation is successful? Will my insurance cover the costs?

 

Medtronic Bladder Control Therapy treats urinary retention not caused by an obstruction; and the symptoms of overactive bladder, including urinary urge incontinence (leakage) and significant symptoms of urgency-frequency. It should be used after you have tried other treatments such as medications and behavioral therapy and they have not worked, or you could not tolerate them.

Next: What Is Medtronic Bladder Control Therapy?

Last updated: 6 Mar 2014